Inclusive Clinical Trials for Rare Disease Diversity

Learn how the 2025 Paris Congress is promoting diversity and equity in rare disease clinical trials. Sessions explore inclusive trial design, minority representation, and gender-specific outcomes in orphan drug development. Experts will share strategies to overcome barriers in underserved populations and ensure fair access to research participation. Hear from patient advocates, regulators, and sponsors building inclusive research models. Empower your organization to support culturally sensitive, ethical, and globally applicable trial practices that reflect the diverse realities of rare disease communities.

    Related Conference of Inclusive Clinical Trials for Rare Disease Diversity

    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    June 08-09, 2026

    20th World Drug Delivery Summit

    London, UK
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Inclusive Clinical Trials for Rare Disease Diversity Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in